Celularity Inc — Director's Dealing 2021

Dec 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celularity Inc (CELU)
CIK: 0001752828
Period of Report: 2021-11-09

Reporting Person: VON ESCHENBACH ANDREW C. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-09	Class A Common Stock	M	100000	$0.28	Acquired	100000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-09	Stock Option (Right to Buy)	$0.28	M	100000	Disposed	2027-06-02	Class A Common Stock (100000)	Direct

Footnotes

F1: This option is fully vested and exercisable.